33.7 C
New York
Friday, June 12, 2026

Tag: chief executive officer

BARRANCO GOLD MINING CORP. ENGAGES RIO MINERALS LTD. TO SUPPORT 2026 EXPLORATION PLANNING AT THE KING PROPERTY

CSE: BARFWB:314OTCQB: BRGMFVANCOUVER, BC, June 9, 2026 /PRNewswire/ - Barranco Gold Mining Corp. ("Barranco" or the "Company") is pleased to announce that it has engaged Rio...

BARRANCO GOLD MINING CORP. ENGAGES RIO MINERALS LTD. TO SUPPORT 2026 EXPLORATION PLANNING AT THE KING PROPERTY

CSE: BARFWB:314OTCQB: BRGMFVANCOUVER, BC, June 9, 2026 /CNW/ - Barranco Gold Mining Corp. ("Barranco" or the "Company") is pleased to announce that it has engaged Rio...

Fusion Fuel Shareholders Approve All Proposed Resolutions, Including Potentially Transformational Royal Uranium Acquisition

Royal Uranium Approval Expected to Advance Company's Potential Transformation into a Diversified Energy Platform

Vivakor Reports First Quarter 2026 Financial Results

Dallas, TX, June 09, 2026 (GLOBE NEWSWIRE) -- Vivakor, Inc. (Nasdaq: VIVK) (“Vivakor” or the “Company”), an integrated provider of energy transportation, storage, reuse, and remediation services, today announced financial and operational results for the three months ended March 31, 2026.

Selagine Plasma to Advance Pooled Plasma Eye Drops for Moderate-to-Severe Dry Eye

Agreement with Selagine, Inc. supports the development of an investigational pooled plasma biologic platform intended to move beyond individualized compounded serum tearsCHICAGO, June 9,...

Abundia Global Impact Group Secures 10-year Feedstock Supply for Cedar Port Waste to Fuels Facility

Agreement expected to supply 40,000 tons per year of plastic waste feedstock, representing approximately 50% of the expected requirement for Abundia’s first Cedar Port plant

VEON Appoints Serkan Ozturk as Chief of Staff & Strategy Officer

Dubai and New York, June 9, 2026 — VEON Ltd. (NASDAQ: VEON), a global digital operator (the “Company” or “VEON”), today announces the appointment of Serkan Ozturk as Chief of Staff & Strategy Officer, effective June 9, 2026.

Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma

- BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham 

- Elraglusib will be assessed in combination with dinutuximab beta plus chemotherapy in patients with relapsed and refractory neuroblastoma

- Complete response in neuroblastoma patient achieved in Phase 1 study of elraglusib in refractory pediatric cancers

CECO Environmental Provides Post-Closing Update on Thermon Transaction

Updates Full Year 2026 Outlook to Incorporate Combination
 Updates Full Year 2026 Outlook to Incorporate Combination

U.S. GoldMining Provides Updates on the 2026 Exploration Program and District Infrastructure Catalysts at its 100% Owned Whistler Project, Alaska

ANCHORAGE, Alaska, June 9, 2026 /CNW/ - U.S. GoldMining Inc. (NASDAQ: USGO) ("U.S. GoldMining" or the "Company") is pleased to provide an update on the...

Uni Hospital Successfully Renews Global Healthcare Accreditation, Strengthening Bulgaria’s Position in International Patient Services

WEST PALM BEACH, Fla., June 9, 2026 /PRNewswire/ -- Global Healthcare Accreditation (GHA) is pleased to announce that Uni Hospital, located in Panagyurishte, Bulgaria,...

BC.GAME Updates BC Engine Page as BETBY Joins Engine Nodes Network

Updated page highlights BC Engine's operating model, live platform data and ecosystem contributors, with BETBY becoming the latest partner in the $BC rewards model.BELIZE...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsChief executive officer